MME Calculator
Morphine Milligram Equivalents — CDC 2022 Conversion Factors
Enter the dose in mg per administration
Concurrent benzodiazepine use significantly increases overdose risk at any MME level
| Drug | Unit | MME Factor |
|---|---|---|
| Morphine (oral) | mg | 1 |
| Morphine (IV/IM/SC) | mg | 3 |
| Hydrocodone (oral) | mg | 1 |
| Oxycodone (oral) | mg | 1.5 |
| Hydromorphone (oral) | mg | 5 |
| Hydromorphone (IV/IM/SC) | mg | 20 |
| Oxymorphone (oral) | mg | 3 |
| Oxymorphone (IV/IM/SC) | mg | 20 |
| Codeine (oral) | mg | 0.15 |
| Tramadol (oral) | mg | 0.2 |
| Tapentadol (oral) | mg | 0.4 |
| Fentanyl Transdermal Patch (mcg/hr) | mcg/hr | 2.4 |
| Fentanyl Buccal/Sublingual (mcg/dose) | mcg | 0.13 |
| Methadone (oral) | mg | 4.7 |
| Buprenorphine Transdermal (mcg/hr) | mcg/hr | 0.72 |
| Meperidine (oral) | mg | 0.1 |
Calculate Morphine Milligram Equivalents
Select an opioid, enter the dose and frequency, then click Calculate to see total daily MME, overdose risk level, and a detailed breakdown.
Important
This calculator is provided for general information only and is not medical advice, diagnosis, or treatment. Results are estimates based on population averages and cannot account for your individual circumstances. Speak to a qualified healthcare professional before acting on anything you read here.
Morphine Milligram Equivalents — CDC 2022 Conversion Factors
The Morphine Milligram Equivalent (MME) Calculator is a clinical reference tool for healthcare providers to calculate the total daily dose of opioid medications expressed in morphine equivalents. MME, also called Morphine Equivalent Dose (MED) or Oral Morphine Equivalent (OME), provides a standardized method for comparing the potency of different opioid medications on a common scale anchored to oral morphine as the reference standard. MME calculations are essential in clinical practice for several reasons. First, they allow prescribers to assess the cumulative opioid burden when a patient is prescribed more than one opioid concurrently. Second, they provide a standardized measure for assessing overdose risk, as the CDC 2022 Clinical Practice Guideline for Prescribing Opioids establishes evidence-based risk thresholds at 20, 50, 90, and 120 MME per day. Third, MME calculations are required for regulatory reporting in many US states through prescription drug monitoring programs (PDMPs). Fourth, they facilitate safe opioid-to-opioid conversion when switching patients from one opioid to another. This calculator uses the conversion factors from the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain, which updated and replaced the 2016 guideline. These are the same factors used by the majority of US state PDMPs, pharmacy benefit managers, and clinical decision support systems. Key factors include Morphine 1.0, Hydrocodone 1.0, Oxycodone 1.5, Hydromorphone 5.0, Oxymorphone 3.0, Codeine 0.15, Tramadol 0.2, Tapentadol 0.4, Methadone 4.7 (simplified), and Fentanyl transdermal 2.4 per mcg/hr. Fentanyl transdermal patches receive special handling because they are dosed in micrograms per hour (mcg/hr) rather than milligrams. The factor of 2.4 per mcg/hr accounts for the 72-hour continuous delivery of the patch and converts the rate to an approximate daily oral morphine equivalent. For example, a 25 mcg/hr fentanyl patch delivers approximately 60 MME per day (25 × 2.4 = 60). Methadone requires special clinical attention because its conversion from morphine equivalents is non-linear and dose-dependent. At lower morphine equivalent doses, methadone appears relatively less potent; at higher doses, it appears much more potent. Additionally, methadone has a prolonged and unpredictable half-life, QTc interval prolongation risk, and complex pharmacokinetics that make conversions inherently dangerous without specialist oversight. The CDC uses a simplified fixed factor of 4.7 for population-level calculations, but clinical conversions to or from methadone should always involve specialist consultation. The calculator supports two primary modes of use. In MME Total mode, you can enter up to three concurrent opioids with their doses and frequencies to calculate the combined total daily MME. This is the most common use case for assessing cumulative opioid load in a patient on multiple opioids. In Opioid Conversion mode, you can calculate the equivalent starting dose of a target opioid when switching from the current regimen. The conversion incorporates an incomplete cross-tolerance adjustment (typically 25-50% dose reduction) which is strongly recommended by clinical guidelines to prevent accidental overdose when rotating opioids. This tool is intended exclusively for use by licensed healthcare providers in clinical settings. It is not intended for patient self-dosing, pediatric patients, patients with cancer-related pain or palliative/hospice care, patients being treated for opioid use disorder, or as a substitute for clinical judgment. All opioid prescribing decisions must incorporate the full clinical picture including diagnosis, comorbidities, concurrent medications, and patient-specific risk factors.
Understanding MME and Opioid Safety
Morphine Milligram Equivalents provide a standardized way to compare opioid potency and assess cumulative opioid burden, which is critical for patient safety and regulatory compliance.
What Are MME and Why Do They Matter
MME (Morphine Milligram Equivalents) express any opioid dose as the equivalent amount of oral morphine. Since different opioids have vastly different potencies — fentanyl is roughly 100 times more potent than morphine by weight — MME provides a common currency for comparison. The CDC uses MME to define risk thresholds in prescribing guidelines, and state PDMPs often flag prescriptions that exceed 90 or 120 MME per day. Understanding a patient's total daily MME is essential for safe prescribing, especially when multiple opioids are prescribed concurrently.
CDC 2022 Risk Thresholds
The 2022 CDC Clinical Practice Guideline identifies evidence-based risk thresholds for opioid overdose. Below 20 MME/day represents the baseline reference risk. From 20-49 MME/day, overdose risk is approximately double the baseline. From 50-89 MME/day, risk is 3.7 times higher, and naloxone co-prescription is recommended. From 90-119 MME/day, strong consideration of dose reduction and specialist consultation is warranted. At 120 MME/day or above, overdose risk is 8.9 times the baseline, carrying an estimated 1.8% annual overdose rate, and specialist involvement is strongly indicated.
Opioid Rotation and Cross-Tolerance
When switching a patient from one opioid to another, the calculated equianalgesic dose is not the recommended starting dose. Incomplete cross-tolerance — the phenomenon where tolerance developed to one opioid does not fully transfer to a new opioid — means patients are more sensitive to the new opioid than the equianalgesic calculation suggests. Clinical guidelines recommend reducing the calculated equianalgesic dose by 25-50% when rotating opioids to prevent inadvertent overdose. The reduction is at the lower end (25%) when switching due to inadequate pain control, and at the higher end (50%) in elderly patients or those with significant comorbidities.
Methadone and Fentanyl Special Considerations
Methadone has complex, non-linear pharmacokinetics that make it uniquely challenging to manage. Its conversion ratio from morphine equivalents changes dramatically with dose: at low doses the ratio may be 4:1, but at very high morphine equivalent doses the ratio may exceed 20:1. Methadone also prolongs the QTc interval, creating cardiac risk, and has an extremely variable half-life of 8-59 hours. Fentanyl transdermal patches are 100 times more potent than morphine by weight and deliver medication continuously over 72 hours. After patch removal, significant drug remains in subcutaneous tissue, and serum levels decline slowly over 17+ hours. Both drugs require extreme caution and specialist involvement for dose conversion.
MME Calculation Formulas
Single Opioid MME
MME = Daily Dose (mg) × MME Conversion Factor
The fundamental formula for calculating morphine milligram equivalents. Multiply the total daily dose of the opioid in milligrams by its CDC 2022 conversion factor. For example, oxycodone 10 mg has a factor of 1.5, so 10 mg = 15 MME.
Total MME from Multiple Opioids
Total MME = Σ (Daily Dose_i × Factor_i) for each opioid i
When a patient takes more than one opioid concurrently, calculate the MME for each drug individually, then sum all values to get the total daily MME burden. This cumulative value determines the patient's overdose risk tier.
Daily Dose from Frequency
Daily Dose = Dose per administration × Number of doses per day
Convert a per-dose prescription to a total daily dose before applying the MME factor. For q6h dosing, multiply by 4; for q8h, multiply by 3; for q12h (BID), multiply by 2.
Fentanyl Patch MME
MME = Patch rate (mcg/hr) × 2.4
Fentanyl transdermal patches are dosed in micrograms per hour rather than milligrams. The CDC factor of 2.4 per mcg/hr accounts for the 72-hour continuous delivery and converts the rate to a daily oral morphine equivalent.
MME Reference Tables
CDC 2022 Opioid MME Conversion Factors
Standard conversion factors from the 2022 CDC Clinical Practice Guideline for Prescribing Opioids. Morphine oral is the reference standard with a factor of 1.0.
| Opioid | Route | MME Factor | Notes |
|---|---|---|---|
| Morphine | Oral | 1.0 | Reference standard |
| Morphine | IV/IM/SC | 3.0 | Parenteral is 3× oral potency |
| Hydrocodone | Oral | 1.0 | Same potency as oral morphine |
| Oxycodone | Oral | 1.5 | 50% more potent than morphine |
| Hydromorphone | Oral | 5.0 | 5× morphine potency |
| Hydromorphone | IV/IM/SC | 20.0 | Very high potency parenteral |
| Oxymorphone | Oral | 3.0 | 3× morphine potency |
| Codeine | Oral | 0.15 | Much weaker than morphine |
| Tramadol | Oral | 0.2 | Weak opioid agonist |
| Tapentadol | Oral | 0.4 | Dual mechanism (mu-opioid + NRI) |
| Fentanyl | Transdermal | 2.4/mcg/hr | Per mcg/hr patch rate |
| Methadone | Oral | 4.7 | Simplified; non-linear in practice |
CDC Overdose Risk Thresholds
Evidence-based risk thresholds from the 2022 CDC guideline for opioid prescribing. Risk increases progressively with higher daily MME.
| MME/day | Risk Level | Relative Risk | Clinical Action |
|---|---|---|---|
| < 20 | Baseline | 1.0× | Standard monitoring |
| 20–49 | Increased | ~2.0× | Patient education, safe storage |
| 50–89 | Moderate | ~3.7× | Co-prescribe naloxone |
| 90–119 | High | ~5.0× | Consider dose reduction, specialist consult |
| ≥ 120 | Very High | ~8.9× | Specialist involvement strongly indicated |
Worked Examples
MME for Oxycodone 10 mg Every 6 Hours
A patient is prescribed oxycodone 10 mg orally every 6 hours (q6h). Calculate the total daily MME.
Determine daily dose: 10 mg × 4 doses/day (q6h) = 40 mg/day
Look up CDC conversion factor for oral oxycodone: 1.5
Calculate MME: 40 mg/day × 1.5 = 60 MME/day
Total daily MME = 60. This falls in the CDC moderate risk tier (50–89 MME/day, ~3.7× overdose risk). Naloxone co-prescription is recommended at this level.
Combined MME from Hydrocodone + Fentanyl Patch
A patient takes hydrocodone 10 mg q8h orally and wears a fentanyl 25 mcg/hr transdermal patch. Calculate the combined total daily MME.
Hydrocodone daily dose: 10 mg × 3 doses/day (q8h) = 30 mg/day
Hydrocodone MME: 30 mg/day × 1.0 (factor) = 30 MME/day
Fentanyl patch MME: 25 mcg/hr × 2.4 (factor) = 60 MME/day
Total MME: 30 + 60 = 90 MME/day
Combined total = 90 MME/day. This reaches the CDC high risk threshold (90–119 MME/day). Guidelines recommend considering dose reduction and pain specialist consultation. Naloxone should be prescribed.
Opioid Rotation: Morphine to Oxycodone with Cross-Tolerance Reduction
A patient on morphine 60 mg/day (oral) needs rotation to oxycodone due to side effects. Calculate the recommended starting dose with 25% cross-tolerance reduction.
Current MME: 60 mg/day × 1.0 (morphine factor) = 60 MME/day
Raw equianalgesic oxycodone dose: 60 MME / 1.5 (oxycodone factor) = 40 mg/day
Apply 25% cross-tolerance reduction: 40 × 0.75 = 30 mg/day
Recommended starting dose: oxycodone 30 mg/day (e.g., 10 mg q8h)
Start oxycodone at 30 mg/day (reduced from calculated 40 mg/day). The 25% reduction accounts for incomplete cross-tolerance. Monitor closely and titrate based on pain control and side effects.
How to Use the MME Calculator
Choose Your Calculator Mode
Select MME Total mode to calculate the combined daily MME from up to three concurrent opioids (e.g., a patient on both scheduled morphine and breakthrough oxycodone). Select Opioid Conversion mode when you need to rotate a patient from their current opioid regimen to a different opioid, and want to calculate a safe starting dose in the new opioid.
Enter Opioid, Dose, and Frequency
Select the opioid from the dropdown. Enter the dose per administration in milligrams (or mcg/hr for fentanyl transdermal and buprenorphine transdermal patches). Select the dosing frequency — q4h through q24h for scheduled dosing, q48h or q72h for extended-interval drugs, or TDD if entering a pre-calculated total daily dose. For multiple opioids, click Add Another Opioid and repeat.
Set Conversion Options (Conversion Mode)
In Opioid Conversion mode, select the target opioid you wish to convert to. Choose a cross-tolerance reduction percentage — the standard clinical recommendation is 25-50% to account for incomplete cross-tolerance when rotating opioids. A 50% reduction is conservative and appropriate for elderly patients or those with high comorbidity burden. Also check the benzodiazepine co-prescription box if the patient is concurrently taking any benzodiazepine.
Review Results and Clinical Recommendations
The calculator displays the total daily MME, overdose risk tier with clinical context, step-by-step calculation breakdown, naloxone recommendation if triggered at 50 MME/day or above, any special drug warnings for methadone or fentanyl, and (in conversion mode) the recommended starting dose in the target opioid. Use the print button to generate a print-friendly summary for patient records.
Frequently Asked Questions
What is the difference between MME, MED, and OME?
Morphine Milligram Equivalents (MME), Morphine Equivalent Dose (MED), and Oral Morphine Equivalent (OME) are all terms for the same fundamental concept: expressing any opioid dose as the equivalent amount of oral morphine. The different names reflect terminology used by different organizations. The CDC primarily uses MME, state PDMPs often use MED, and some international clinical guidelines use OME. This calculator uses the CDC 2022 conversion factors, which are the standard for US clinical practice. The numerical result is the same regardless of which term is used, as they all anchor to oral morphine as the reference with a factor of 1.0.
Why is my MME for fentanyl patch so high?
Fentanyl transdermal patches are extremely potent — approximately 100 times more potent than morphine by weight. The CDC 2022 conversion factor for fentanyl transdermal is 2.4 per mcg/hr. This means a 25 mcg/hr patch equals approximately 60 MME per day (25 × 2.4 = 60), a 50 mcg/hr patch equals approximately 120 MME per day, and a 100 mcg/hr patch equals approximately 240 MME per day. These numbers are accurate and reflect the very high potency of this medication. A 100 mcg/hr fentanyl patch is well above the CDC 120 MME/day threshold associated with 8.9x higher overdose risk. The factor of 2.4 already accounts for the 72-hour patch delivery cycle, converting the hourly rate to a daily morphine equivalent.
Can I use this calculator to convert between any two opioids?
The calculator supports conversion between most opioids on the list using the standard equianalgesic approach. However, several important limitations apply. Converting to or from methadone should always involve specialist consultation because methadone's conversion ratio is non-linear and dose-dependent — a calculated dose may be dangerously inaccurate. Converting to buprenorphine (for pain, not OUD treatment) requires careful clinical assessment. The calculated result in Conversion mode represents a starting dose estimate after cross-tolerance reduction — it should never be interpreted as an exact equianalgesic dose or used without clinical adjustment. Clinical guidelines universally recommend close monitoring when initiating a new opioid after rotation.
What does the incomplete cross-tolerance reduction mean?
When a patient develops tolerance to one opioid, that tolerance does not fully transfer to a different opioid. This phenomenon, called incomplete cross-tolerance, means patients are more sensitive to a new opioid than the equianalgesic calculation would suggest. If you simply converted a patient's full morphine dose to oxycodone, they would likely be overdosed because they would respond to a smaller oxycodone dose than calculated. Clinical guidelines recommend reducing the calculated equianalgesic dose by 25-50% when rotating opioids. Use 25% reduction when switching due to inadequate pain control (the patient still needs near-full pain coverage). Use 50% reduction as the standard approach for most rotations, and consider 50-75% in elderly patients, those with severe comorbidities, or in cases of concern for high sensitivity.
Why does this calculator show a warning for methadone?
Methadone is one of the most dangerous opioids from a prescribing safety perspective, with multiple unique properties that make standard MME conversion highly unreliable. Its half-life ranges from 8 to 59 hours and is highly variable between individuals, making it easy to accumulate to toxic levels. Its analgesic duration (4-8 hours) is much shorter than its half-life, leading some providers to incorrectly dose it more frequently. It causes QTc interval prolongation, creating cardiac arrhythmia risk — baseline and follow-up ECG monitoring is required. Its conversion ratio from morphine equivalents is non-linear: at low doses a 4:1 morphine-to-methadone ratio applies, but at very high morphine equivalent doses the ratio can exceed 20:1. The CDC uses a simplified fixed factor of 4.7 for surveillance purposes, which is not appropriate for clinical dose conversion.
When should I consider co-prescribing naloxone for a patient on opioids?
The CDC 2022 guideline recommends offering naloxone to patients receiving opioid therapy who are at increased risk of opioid overdose. This includes patients on 50 MME/day or higher (as calculated by this tool), patients who concurrently use benzodiazepines or other CNS depressants, patients with sleep apnea or other respiratory conditions, patients with a history of substance use disorder, patients who have experienced a prior overdose, and patients who live alone or have limited emergency access. Naloxone is safe to prescribe and is available as nasal spray (Narcan) or auto-injector (Evzio). When prescribing naloxone, educate both the patient and their household members or caregivers on how and when to use it. Naloxone access and education should be considered a routine part of opioid prescribing at higher doses.
Related Tools
Dosage Calculator
Calculate medication dosages based on weight, age, and clinical parameters for safe prescribing.
BSA Calculator
Calculate body surface area using multiple validated formulas for drug dosing and clinical assessment.
BMI Calculator
Calculate Body Mass Index with WHO classification, health risk interpretation, and weight management guidance.
GFR Calculator
Estimate glomerular filtration rate for kidney function assessment and medication dose adjustment.
Blood Pressure Calculator
Classify blood pressure readings using AHA/ACC guidelines with risk assessment and monitoring recommendations.